Biological products and their manufacture are progressing to unparalleled levels of complexity. Examples include engineered biocatalysts, antibody-drug conjugates, multivalent vaccines and cellular therapies.
The Engineering and Physical Sciences Research Council (EPSRC) is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £850m a year.
Cell and Stem Cell based therapies are revolutionising medical treatment. Immunotherapies such as CAR-T cells are effectively treating previously terminal diseases and are poised to reach mass markets.
The development of sustainable bio-manufacturing routes for both platform and high-value chemicals (e.g. biofuels, food supplement) is a high priority area to establish a low carbon economy and achieve energy/food security.